Metasphere Labs Inc.
LABZD
$0.2012
$0.01528.17%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 174.60K | 672.90K | 1.14M | 1.62M | 1.79M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 174.60K | 672.90K | 1.14M | 1.62M | 1.79M |
| Cost of Revenue | 40.50K | 132.10K | 188.50K | 259.50K | 282.20K |
| Gross Profit | 134.30K | 540.90K | 950.60K | 1.36M | 1.51M |
| SG&A Expenses | 711.80K | 811.70K | 804.30K | 770.70K | 844.80K |
| Depreciation & Amortization | 32.70K | 62.70K | 67.30K | 82.40K | 86.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 820.50K | 1.04M | 1.10M | 1.13M | 1.22M |
| Operating Income | -645.80K | -369.00K | 43.50K | 486.30K | 577.40K |
| Income Before Tax | -1.20M | -892.50K | -439.50K | -2.10K | -266.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.20 | -0.89 | -0.44 | 0.00 | -0.27 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 30.20K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.20M | -892.50K | -439.50K | -2.10K | -236.60K |
| EBIT | -645.80K | -369.00K | 43.50K | 486.30K | 577.40K |
| EBITDA | -627.90K | -325.60K | 87.20K | 540.50K | 668.40K |
| EPS Basic | -0.14 | -0.11 | -0.02 | 0.45 | -1.30 |
| Normalized Basic EPS | -0.05 | -0.03 | 0.02 | 0.29 | 0.08 |
| EPS Diluted | -0.16 | -0.12 | -0.06 | 0.41 | -1.34 |
| Normalized Diluted EPS | -0.05 | -0.03 | -0.01 | 0.27 | 0.06 |
| Average Basic Shares Outstanding | 37.37M | 37.45M | 31.25M | 22.48M | 15.32M |
| Average Diluted Shares Outstanding | 37.37M | 41.52M | 38.54M | 29.77M | 22.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |